tirzepatide + bpc-157 injection Peptide Tirzepatide BPC-157 B6 | Advanced

IgA vasculitis causes skin, joints, intestines, and kidneys' small blood vessels to inflate and bleed

Controlling the role of BPC 157 likely involves its particular interaction with the major systems involved in wound healing, such as the NO-system (counteracted harmful events, arising from either NO-blockade or NOS-substrate application) (Sikiric et al., 2014) and the prostaglandins system (i.e., large extent of the counteracted NSAIDs toxicity (Sikiric et al., 2013) as well as counteracted developing and already formed adjuvant arthritis in rats (Sikiric et al., 1997c))

Shenzhen Basic Research Program (grant JCYJ20220530151415034 to W.F.X)

How This Works BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein [2]

Its now being investigated for potential longevity benefits and as a treatment for age-related macular degeneration